| Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation AC Raddant, AF Russo Expert reviews in molecular medicine 13, e36, 2011 | 250 | 2011 |
| A potential preclinical migraine model: CGRP-sensitized mice AF Russo, A Kuburas, EA Kaiser, AC Raddant, A Recober Molecular and cellular pharmacology 1 (5), 264, 2009 | 81 | 2009 |
| CGRP receptor antagonist activity of olcegepant depends on the signalling pathway measured CS Walker, AC Raddant, MJ Woolley, AF Russo, DL Hay Cephalalgia 38 (3), 437-451, 2018 | 70 | 2018 |
| Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers AF Russo, EA Kaiser, A Recober, A Kuburas, AC Raddant, ... US Patent 9,708,393, 2017 | 62 | 2017 |
| Epigenetic regulation of the calcitonin gene–related peptide gene in trigeminal glia KY Park, JR Fletcher, AC Raddant, AF Russo Cephalalgia 31 (5), 614-624, 2011 | 45 | 2011 |
| Induction of calcitonin gene-related peptide expression in rats by cortical spreading depression Y Wang, AE Tye, J Zhao, D Ma, AC Raddant, F Bu, BL Spector, ... Cephalalgia 39 (3), 333-341, 2019 | 40 | 2019 |
| Reactive oxygen species induce procalcitonin expression in trigeminal ganglia glia AC Raddant, AF Russo Headache: The Journal of Head and Face Pain 54 (3), 472-484, 2014 | 39 | 2014 |
| Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels AF Russo, EA Kaiser, A Recober, A Kuburas, AC Raddant, ... US Patent 9,855,332, 2018 | 36 | 2018 |
| Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or light a version in subjects in need thereof, especially migraine sufferers AF Russo, EA Kaiser, A Recober, A Kuburas, AC Raddant, ... US Patent 11,325,967, 2022 | | 2022 |
| Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels AF Russo, EA Kaiser, A Recober, A Kuburas, AC Raddant, ... US Patent 11,027,018, 2021 | | 2021 |
| Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with diseases or treatments that result in elevated CGRP levels AF Russo, EA Kaiser, A Recober, A Kuburas, AC Raddant, ... US Patent 10,765,746, 2020 | | 2020 |
| Regulation of CGRP gene expression and effects on light aversive behavior AC Raddant The University of Iowa, 2013 | | 2013 |
| AAV2 Transduction Is Regulated by FAK and c-Src PM Kaminsky, AC Raddant, JF Engelhardt MOLECULAR THERAPY 17, S146-S147, 2009 | | 2009 |
